$3.3 billion senior secured notes offering
Company: Core Scientific
The claim, verbatim
Core Scientific's subsidiary priced $3.3 billion of 7.750% senior secured notes due 2031 at 99.250% of principal amount
Source (primary)
core-scientific 8-K exhibit (d47435dex991.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-09-08)Live source ↗
Quote: “announced that its wholly-owned subsidiary, Core Scientific Finance I LLC (the "Issuer"), has priced an offering of $3.3 billion aggregate principal amount of 7.750% senior secured notes due 2031 (the "Notes") at an issue price equal to 99.250% of the principal amount thereof”
How we checked this
Checked on September 19, 2026. The cited source supports every part of this claim.
The document states all details of the pricing, rate, maturity, and issue price.
Confirmed in the source:
- Core Scientific's wholly-owned subsidiary priced $3.3 billion aggregate principal amount of senior secured notes
- The notes carry a 7.750% rate and are due 2031
- The notes were priced at 99.250% of principal amount
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312526208905/d47435dex991.htm) in full (7,520 characters, retrieved September 8, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d47435dex991.htm)
Quote: “announced that its wholly-owned subsidiary, Core Scientific Finance I LLC (the "Issuer"), has priced an offering of $3.3 billion aggregate principal amount of 7.750% senior secured notes due 2031 (the "Notes") at an issue price equal to 99.250% of the principal amount thereof”